Your account is not claimed yet. You can sign up with ORCID to claim your account.

Nancy E Sealover

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Rheumatoid Arthritis

Extracellular Matrix

Top Venues

Science signaling

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Nancy E Sealover, Robert L Kortum
Heterogeneity in RAS mutations: One size does not fit all. Science signaling 15 (746) (2022)
Katie E Hebron, Xiaolin Wan, Jacob S Roth, David J Liewehr, Nancy E Sealover, William J E Frye, Angela Kim, Stacey Stauffer, Olivia L Perkins, Wenyue Sun, Kristine A Isanogle, Christina M Robinson, Amy James, Parirokh Awasthi, Priya Shankarappa, Xiaoling Luo, Haiyan Lei, Donna Butcher, Roberta Smith, Elijah F Edmondson, Jin-Qiu Chen, Noemi Kedei, Cody J Peer, Jack F Shern, William Douglas Figg, Lu Chen, Matthew D Hall, Simone Difilippantonio, Frederic G Barr, Robert L Kortum, Robert W Robey, Angelina V Vaseva, Javed Khan, Marielle E Yohe
The combination of trametinib and ganitumab is effective in RAS-mutated PAX-fusion negative rhabdomyosarcoma models. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Erin Sheffels, Nancy E Sealover, Patricia L Theard, Robert L Kortum
Anchorage-independent growth conditions reveal a differential SOS2 dependence for transformation and survival in RAS-mutant cancer cells. Small GTPases 12 (1) (2019)
Erin Sheffels, Nancy E Sealover, Chenyue Wang, Do Hyung Kim, Isabella A Vazirani, Elizabeth Lee, Elizabeth M Terrell, Deborah K Morrison, Ji Luo, Robert L Kortum
Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation. Science signaling 11 (546) (2018)